Peter M. Glazer
Affiliations: | Yale University, New Haven, CT |
Area:
Genetics, Cell Biology, RadiologyGoogle:
"Peter Glazer"Children
Sign in to add traineeLaurent Lacroix | grad student | 1996-1997 | Yale Med Sch (Chemistry Tree) |
Phillip P. Chan | grad student | 2000 | Yale |
Shani Peretz | grad student | 2001 | Yale |
Jianling Yuan | grad student | 2002 | Yale |
Margaret A. Macris | grad student | 2003 | Yale |
Ranjit S. Bindra | grad student | 2005 | Yale |
Shannon L. Gibson | grad student | 2005 | Yale |
Melissa P. Knauert | grad student | 2005 | Yale |
Jean Y. Kuan | grad student | 2006 | Yale |
Joanna Y. Chin | grad student | 2010 | Yale |
Erica B. Schleifman | grad student | 2011 | Yale |
Nicole A. McNeer | grad student | 2014 | Yale School of Medicine (BME Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Oyaghire SN, Quijano E, Perera JDR, et al. (2023) DNA recognition and induced genome modification by a hydroxymethyl-γ tail-clamp peptide nucleic acid. Cell Reports. Physical Science. 4 |
Putman R, Ricciardi AS, Carufe KEW, et al. (2022) Nanoparticle-mediated genome editing in single-cell embryos via peptide nucleic acids. Bioengineering & Translational Medicine. 8: e10458 |
Piotrowski-Daspit AS, Barone C, Lin CY, et al. (2022) In vivo correction of cystic fibrosis mediated by PNA nanoparticles. Science Advances. 8: eabo0522 |
Singh C, Bindra RS, Glazer PM, et al. (2022) Metastatic and multiply relapsed SDH-deficient GIST and paraganglioma displays clinical response to combined poly ADP-ribose polymerase inhibition and temozolomide. Pediatric Blood & Cancer. e30020 |
Eder JP, Doroshow DB, Do KT, et al. (2021) Clinical Efficacy of Olaparib in Mutant Mesenchymal Sarcomas. Jco Precision Oncology. 5: 466-472 |
Gayle S, Aiello R, Leelatian N, et al. (2021) Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'. Nar Cancer. 3: zcab047 |
Dow J, Krysztofiak A, Liu Y, et al. (2021) Vulnerability of IDH1-Mutant Cancers to Histone Deacetylase Inhibition via Orthogonal Suppression of DNA Repair. Molecular Cancer Research : McR |
Gayle S, Aiello R, Leelatian N, et al. (2021) Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity. Nar Cancer. 3: zcab021 |
Saha K, Sontheimer EJ, Brooks PJ, et al. (2021) The NIH Somatic Cell Genome Editing program. Nature. 592: 195-204 |
Ullrich SJ, Freedman-Weiss M, Ahle S, et al. (2021) Nanoparticles for Delivery of Agents to Fetal Lungs. Acta Biomaterialia |